![]() ANI Pharmaceuticals ANI Pharmaceuticals develops, manufactures and markets top quality prescription pharmaceuticals, made in the U.S.A. | ![]() Dermavant Sciences Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology. | ![]() Merus Merus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients. | |
Founding Date | Founding Date 1996 | Founding Date 2016 | Founding Date 2003 |
Type | Type Public | Type Subsidiary | Type Public |
Tags | |||
Locations | Locations Baudette, US HQ Oakville, CA Baudette, US | Locations Long Beach, US HQ Basel, CH Durham, US Morrisville, US New York, US Phoenix, US | Locations Utrecht, NL HQ Cambridge, US |
Employees | Employees 33813% increase | Employees 286 | Employees 172 |
Valuation ($) | Valuation ($) 1.2 b | Valuation ($) N/A | Valuation ($) 3.6 b |
Financial | |||
Revenue (est.) | Revenue (est.) $486.8m (FY, 2023) | Revenue (est.) N/A | Revenue (est.) $43.9m (FY, 2023) |
Net income | Net income $18.8m (FY, 2023) | Net income ($255.3m) (FY, 2019) | Net income ($154.9m) (FY, 2023) |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 200m | Total funding raised $ 149.3m |
Dermavant Sciences, a clinical-stage biopharmaceutical company, develops and commercializes therapeutics in medical dermatology.
View companyMerus is a clinical-stage immuno-oncology company developing innovative bispecific antibody therapeutics with the goal of treating and potentially curing cancer patients.
View company